| For: | Elsayed MOK, Talkhan MG. Asymptomatic bile duct stones: The devil is in the details. World J Gastrointest Endosc 2024; 16(5): 227-231 [PMID: 38813578 DOI: 10.4253/wjge.v16.i5.227] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v16/i5/227.htm |
| Number | Citing Articles |
| 1 |
Ryunosuke Hakuta, Ryota Nakabayashi, Yutaka Shimamatsu, Nao Otsuka, Yukiko Takayama, Masataka Kikuyama, Yousuke Nakai. Current treatment strategy for asymptomatic bile duct stones. Expert Review of Gastroenterology & Hepatology 2025; 19(12): 1231 doi: 10.1080/17474124.2025.2588611
|
| 2 |
Ping Zhang, Long-jiang Chen, Dan-feng Liu, Sreeja Dattachoudhury. Risk Factors and Predictive Modeling of Occult Choledocholithiasis in Patients with Cholecystolithiasis. Gastroenterology Research and Practice 2026; 2026(1) doi: 10.1155/grp/9419737
|
| 3 |
Zachary L. Smith, Tasmia Amjad, Mikaela Hoard, Abigail Thorgerson, Phillip R. Chisholm, Kulwinder S. Dua, B. Joseph Elmunzer, Nauzer Forbes, Srivats Madhavan, Rajesh N. Keswani, Matthew T. Peller, Sachin Wani, Hassaan Zia, Aprill Z. Dawson, Duo Yu. Uncomplicated Choledocholithiasis in Elderly Patients: A Target Trial Emulation Comparing Observation and Endoscopic Retrograde Cholangiopancreatography. Clinical Gastroenterology and Hepatology 2026; doi: 10.1016/j.cgh.2026.02.010
|
| 4 |
Renato Pitesa, Wai Yan (Rachel) Yuen, Nadia Meyer, Garth Poole, Primal Parry Singh. When Enzymes Mislead: Assessing the Value of MRCP in Suspected Choledocholithiasis. ANZ Journal of Surgery 2026; doi: 10.1111/ans.70584
|